Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Nov 2012

Cossu-Rocca Paolo, Contini Marcella, Uras Maria Gabriela, Muroni Maria Rosaria, Pili Francesca, Carru Ciriaco, Bosincu Luisanna, Massarelli Giovannino, Nogales Francisco F, De Miglio Maria Rosaria

Abstract excerpt

Endometrial stromal sarcomas (ESS) are rare uterine malignant mesenchymal neoplasms, which are currently treated by surgery, as effective adjuvant therapies have not yet been established. Tyrosine kinase inhibitors have rarely been applied in ESS therapy, with few reports describing imatinib responsivity. The aim of this study was to analyze the status of different tyrosine kinase receptors in an ESS series, in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Endometrial Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Immunohistochemistry

Share to Proto-Oncogene Proteins c-kit

Share to Receptor, Platelet-Derived Growth Factor alpha

Share to Receptor, Platelet-Derived Growth Factor beta

Share to Receptor Protein-Tyrosine Kinases

Source

Identifiers

PMID: 23018215
DOI: 10.1097/PGP.0b013e31824fe289

Genes

EGFR
KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis.PMID 23018215Read ↗

Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.Semantic proximity Read ↗

ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.Semantic proximity Read ↗

Immunohistochemical and Molecular Characterization of Endometrial Stromal SarcomasSemantic proximity Read ↗

Endometrial stromal sarcoma--observational evidence of a genetic background?Semantic proximity Read ↗

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis.Semantic proximity Read ↗

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.Semantic proximity Read ↗

Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.Semantic proximity Read ↗

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.Semantic proximity Read ↗

Frequency of Known Gene Rearrangements in Endometrial Stromal TumorsSemantic proximity Read ↗

Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region.Semantic proximity Read ↗

Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature.Semantic proximity Read ↗

EGFR isoforms and gene regulation in human endometrial cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.